• Mashup Score: 0
    Close Menu - 7 month(s) ago

    Health care providers require ongoing training and education in the field of cardiology, including updates on diagnostic and treatment strategies that assess the risk of coronary artery disease (CAD), peripheral artery disease, congestive heart failure, valvular heart disease, arrhythmias and preventive cardiology. It’s imperative that providers stay abreast of new and emerging approaches and understand best practices needed to improve patient outcomes and reduce morbidity and mortality related to CVD.

    Source: medschool.uci.edu
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASPCardio
      ASPCardio

      Save the Date for UC Irvine's 2023 Symposium For CVD Prevention! A Pre-emptive Strike: Addressing Cardiovascular Disease Through Preventive Strategies Saturday, October 28, 2023 | 7:00 am to 4:00pm Register to attend: https://t.co/jXWjsjhYsA https://t.co/j0o7aNvxkx

  • Mashup Score: 2
    ScienceDirect - 8 month(s) ago

    Read the latest articles of American Journal of Preventive Cardiology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

    Source: www.sciencedirect.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASPCardio
      ASPCardio

      #APSC2023 Abstracts have been published as a supplement to the Sept. 2023 issue of @AJPCardio! Congratulations to the 2023 authors. We look forward to another amazing year of submissions at #ASPC2024 (portal will open in December). https://t.co/tjcXULgUDq https://t.co/QR0XBuRZ2t

  • Mashup Score: 1
    Instagram - 9 month(s) ago

    Palo Alto, Calif. – August 22, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announce the U.S. Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices Advisory Committee met to discuss the pre-market approval application (PMA) for the Paradise™ Ultrasound Renal Denervation (RDN) system, indicated to reduce blood pressure in patients with hypertension. The overall vote from the committee was

    Source: www.recormedical.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASPCardio
      ASPCardio

      Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension. Read more... https://t.co/EWH8pDGdqi https://t.co/6bD2vOg1QS

Load More